| Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL) (NCT07288814) | Sun Yat-Sen University Cancer Center | 2025-12-08 |
| A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia (NCT07134088) | Amgen | 2025-12-08 |
| CMTS0515-auWMT for Radiation Enteritis (NCT07331688) | The Second Hospital of Nanjing Medical University | 2025-12-08 |
| A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects (NCT07269756) | Shandong Suncadia Medicine Co., Ltd. | 2025-12-07 |
| Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy (NCT07287033) | Mabylon AG | 2025-12-06 |
| Phase 1 Study of CLR 125 in Triple Negative Breast Cancer (NCT07311993) | Cellectar Biosciences, Inc. | 2025-12-05 |
| First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD) (NCT07216066) | Regeneron Pharmaceuticals | 2025-12-05 |
| STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma (NCT06626256) | City of Hope Medical Center | 2025-12-05 |
| Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children (NCT07193719) | Charite University, Berlin, Germany | 2025-12-05 |
| A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes (NCT07221162) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-12-05 |
| Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors (NCT07245901) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-12-05 |
| A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies (NCT07173595) | Qilu Pharmaceutical Co., Ltd. | 2025-12-05 |
| A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants (NCT07294235) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-12-05 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours (NCT07213817) | Ipsen | 2025-12-05 |
| The Phase Ⅰd Clinical Trial of Hydronidone Capsules (NCT07262346) | Beijing Continent Pharmaceutical Co, Ltd. | 2025-12-05 |
| A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC (NCT07226986) | Novartis Pharmaceuticals | 2025-12-05 |
| A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants. (NCT07272629) | Sanofi | 2025-12-04 |
| A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes (NCT07568678) | Hua Medicine Limited | 2025-12-04 |
| Healthy Volunteer Study (NCT07270783) | InventisBio Co., Ltd | 2025-12-04 |
| Bioequivalence and Adhesion of a Rotigotine Patch in Healthy Subjects (NCT07769359) | Amarin Technologies S.A.U. | 2025-12-04 |
| A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia (NCT07327359) | Olix Pharmaceuticals, Inc. | 2025-12-04 |
| Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants (NCT07236411) | Candid Therapeutics | 2025-12-04 |
| A Clinical Study to Evaluate GK01 Cell Injection in Combination With PD-1 Monoclonal Antibody for Advanced Solid Tumors (NCT07407985) | Tianjin Medical University Cancer Institute and Hospital | 2025-12-04 |
| Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN) (NCT06980948) | Sangamo Therapeutics | 2025-12-04 |
| A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity (NCT07310901) | Corbus Pharmaceuticals Inc. | 2025-12-04 |
| Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG) (NCT07272889) | Atea Pharmaceuticals, Inc. | 2025-12-04 |
| Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation. (NCT07670468) | LucasBio | 2025-12-04 |
| Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors (NCT07299747) | VelaVigo Bio Inc | 2025-12-04 |
| An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors (NCT07371663) | Beijing Tide Pharmaceutical Co., Ltd | 2025-12-03 |
| Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies (NCT07284927) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2025-12-03 |
| A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC) (NCT07244341) | Daiichi Sankyo | 2025-12-03 |
| Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. (NCT07165132) | RayzeBio, Inc. | 2025-12-03 |
| A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors (NCT07277270) | GlaxoSmithKline | 2025-12-03 |
| Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma (NCT06961357) | H. Lee Moffitt Cancer Center and Research Institute | 2025-12-03 |
| A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181 (NCT07446816) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2025-12-03 |
| Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia (NCT07317544) | Absci Pty Ltd. | 2025-12-03 |
| Study to Evaluate Safety of C-1101 Versus Sterile Saline in Adults With Chronic Painful Lumbosacral Radiculopathy (NCT07264270) | Consano Bio | 2025-12-03 |
| Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM (NCT07209241) | University of Pennsylvania | 2025-12-03 |
| A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors (NCT07229612) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2025-12-03 |
| First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD) (NCT07285889) | First Affiliated Hospital of Zhejiang University | 2025-12-03 |
| A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 (NCT07292168) | Kidney Cancer Research Bureau | 2025-12-02 |
| A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer (NCT07042802) | Nanjing Leads Biolabs Co.,Ltd | 2025-12-02 |
| A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma (NCT07116486) | M.D. Anderson Cancer Center | 2025-12-02 |
| Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants (NCT07201558) | AstraZeneca | 2025-12-02 |
| A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis (NCT07258849) | Eli Lilly and Company | 2025-12-02 |
| Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma (NCT07093554) | Medical College of Wisconsin | 2025-12-02 |
| Study to Evaluate CAY001 in Healthy Volunteers (NCT06845839) | Cayuga Biotech, Inc. | 2025-12-02 |
| A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B (NCT07771140) | Sunshine Lake Pharma Co., Ltd. | 2025-12-02 |
| NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma (NCT07114367) | NOBO Medicine | 2025-12-02 |
| A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors (NCT07229586) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2025-12-02 |
| A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors (NCT07317505) | Conjupro Biotherapeutics, Inc. | 2025-12-02 |
| Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer (NCT06324240) | Emory University | 2025-12-02 |
| A Phase 1 Study of CLYM116 in Normal Healthy Volunteers (NCT07248865) | Climb Bio, Inc. | 2025-12-02 |
| Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies (NCT06647979) | Daniel Bauer | 2025-12-01 |
| Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition. (NCT07267221) | Daewoong Pharmaceutical Co. LTD. | 2025-12-01 |
| Immune Cell Therapy for Advanced Solid Tumors (NCT07260058) | Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. | 2025-12-01 |
| Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas (NCT06455189) | Case Comprehensive Cancer Center | 2025-12-01 |
| Safety and Preliminary Effectiveness Study of Mesenchymal Stem Cells, HeXell-2020, in Patients With Stable Coronary Artery Disease (NCT07137104) | Hexun Biosciences Co., LTD. | 2025-12-01 |
| Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders (NCT04630847) | ProgenaBiome | 2025-12-01 |
| Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT07086521) | Restem, LLC. | 2025-12-01 |
| Effect of Liberal and Restrictive IV Fluids on Recovery After Gallbladder Surgery (NCT07488078) | King Edward Medical University | 2025-12-01 |
| A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS (NCT07169175) | SineuGene Therapeutics Co., Ltd. | 2025-12-01 |
| Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer (NCT07261592) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2025-12-01 |
| OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis (NCT06669403) | Op-T LLC | 2025-12-01 |
| Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC (NCT07281716) | Dan Feng | 2025-12-01 |
| Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation (NCT07245381) | Dr. Itay GoorAryeh | 2025-12-01 |
| Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT (NCT06551584) | Stanford University | 2025-12-01 |
| Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScan (NCT07054593) | Envivo Bio Inc | 2025-12-01 |
| A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects (NCT07219940) | Shine-On Biomedical Co., Ltd. | 2025-12-01 |
| Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol (NCT07257497) | West China Hospital | 2025-12-01 |
| A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis (NCT07235384) | Zai Lab (Shanghai) Co., Ltd. | 2025-12-01 |
| Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects (NCT07309042) | Beijing Inno Medicine Co., Ltd. | 2025-12-01 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus (NCT05018858) | The Foundation for Orthopaedics and Regenerative Medicine | 2025-12-01 |
| First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors (NCT07284186) | Plexium, Inc. | 2025-12-01 |
| A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer (NCT07269158) | Yonsei University | 2025-12-01 |
| Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia (NCT07297173) | Beijing 302 Hospital | 2025-12-01 |
| Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum Disorder (NCT06561009) | Tianjin Medical University General Hospital | 2025-12-01 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI (NCT05018832) | The Foundation for Orthopaedics and Regenerative Medicine | 2025-12-01 |
| A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease (NCT07301502) | Akeso | 2025-12-01 |
| Assessment of Corneal Endothelial Function Following Hypoxic Stress (NCT04175938) | Massachusetts Eye and Ear Infirmary | 2025-12-01 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS (NCT05003921) | The Foundation for Orthopaedics and Regenerative Medicine | 2025-12-01 |
| Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single Subcutaneous Dose Administration Using a Reusable ServoPen With Cartridge as Compared to Administration Using a Syringe Drawn From an Ampule (NCT07312643) | RECORDATI GROUP | 2025-12-01 |
| Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia (NCT07263906) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-12-01 |
| Clinical Research on Stem Cell Therapy for Parkinson's Disease (NCT07232147) | Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. | 2025-12-01 |
| Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. (NCT07227012) | Pfizer | 2025-12-01 |
| A PROSPECTIVE, SINGLE-CENTERED, ASSESSOR-BLINDED STUDY TO EVALUATE THE CLINICAL EFFICACY OF THE PROPOSED CELL/TISSUE HISTOPATHOLOGY PROCESSOR CCELL (CONFOCAL FLUORESCENCE ENDOMICROSCOPY) FOR INTRAOPERATIVE DIAGNOSIS IN BRAIN TUMORS (NCT07254845) | VPIX Medical | 2025-12-01 |
| Evaluating Microneedling With CBD and Hempseed Oil for Acne Vulgaris Safety and Efficacy (NCT06362889) | Rejuva Medical Aesthetics | 2025-12-01 |
| Effect of Progesterone Administration on Severely Head Injured Patients (NCT06631547) | Assiut University | 2025-12-01 |
| A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy (NCT07241104) | AstraZeneca | 2025-12-01 |
| Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects (NCT07277933) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2025-12-01 |
| Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer (NCT07244393) | Cellbion Co., Ltd. | 2025-12-01 |
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors (NCT07291050) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2025-12-01 |
| Effect of Platelet-Rich Plasma Injection on Wound Healing After Fistulotomy for Simple Anal Fistula Randomized Controlled Trial (RCT) (NCT07248007) | Assiut University | 2025-12-01 |
| Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome (NCT07312864) | Beijing Friendship Hospital | 2025-12-01 |
| A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A (NCT07152873) | Addpharma Inc. | 2025-12-01 |
| A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs (NCT07343245) | Daewon Pharmaceutical Co., Ltd. | 2025-12-01 |
| Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers (NCT07231861) | AJU Pharm Co., Ltd. | 2025-12-01 |
| TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors (NCT07266298) | Neowise Biotechnology | 2025-12-01 |
| Linaclotide for Colonoscopy Bowel Prep (NCT06692673) | University of Florida | 2025-12-01 |
| A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma (NCT07306299) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-12-01 |